Blood flow measurement devices market

Blood Flow Measurement Devices Market, by Product Type (Ultrasonic Doppler Blood Flowmeters, Laser Doppler Blood Flowmeters and Electromagnetic Blood Flowmeters), by Application (Gastroenterology, Diabetes, Dermatology, Cardiovascular Disease, Intra-cranial Monitoring in Stroke and Brain Injury and Others), by End User (Hospitals, Clinics and Specialty Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Request Free Sample

Sep 2022
CMI183
150 Pages
Excel & Pdf
Medical Devices

Summary

Biopharmaceuticals are drugs that are partially or fully manufactured, or extracted from biological sources such as proteins, viruses, and cells. Biopharmaceuticals contain variety of products such as monoclonal antibodies, vaccines, recombinant human insulin, human growth hormone, erythropoietin, interferon, colony stimulating factor, and blood factors. Different from traditional drugs synthesized from chemical processes, majority of biopharmaceutical products are derived from biological processes such as recombinant deoxyribonucleic acid (DNA) technologies

Global blood flow measurement devices market is estimated to be valued at US$ 639.5 million in 2022 and is expected to exhibit a CAGR of 8.8 % during the forecast period (2022-2030).

Figure 1. Global Blood Flow Measurement Devices Market Share (%), by Application, 2022

Increasing prevalence of peripheral vascular diseases are expected to drive growth of the blood flow measurement devices market

Increasing prevalence of peripheral vascular diseases are expected to drive growth of the blood flow measurement devices market. For instance, according to National Center for Biotechnology Information May 2018 data, over 200 million people suffer from peripheral arterial disease worldwide.

Figure 2. Global Blood Flow Measurement Devices Market Share (%), by Region, 2022

Increasing development of biodegradable flow measurement devices are expected to drive market growth during the forecast period.

Increasing development of biodegradable flow measurement devices are expected to drive market growth during the forecast period.

Blood Flow Measurement Devices Market Report Coverage

Report Coverage	Details
Base Year:	2021	Market Size in 2022:	US$ 639.5 Mn
Historical Data for:	2017 to 2020	Forecast Period:	2022 to 2030
Forecast Period 2022 to 2030 CAGR:	8.8%	2030 Value Projection:	US$ 1,253.9 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Ultrasonic Doppler Blood Flowmeters, Laser Doppler Blood Flowmeters, Electromagnetic Blood Flowmeters By Application: Gastroenterology, Diabetes, Dermatology, Cardiovascular Disease, Intra-cranial Monitoring in Stroke and Brain Injury, Others (Tumor Monitoring and Angiogenesis) By End User: Hospitals, Clinics, Specialty Centers
Companies covered:	Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc., Ace Medicals, Carolina Medical Plc, and Compumedics Ltd.
Growth Drivers:	Increasing prevalence of peripheral vascular diseases Increasing development of biodegradable flow measurement devices
Restraints & Challenges:	Stringent regulatory scenario

Global Blood Flow Measurement Devices Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

COVID-19 has affected the economy in three main ways: by directly affecting production and demand of drugs and vaccines, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries, such as China, India, Saudi Arabia, U.A.E., Egypt, and others, faced problems with regard to the transportation of drugs and vaccines from one place to another.

The increased number of patients experiencing chronic diseases and covid-19 at the same time has led to an increase in the usage of blood flow measurement devices as the covid arrived at the end of the previous forecast period. To stop the infection from spreading, the governments imposed lockdowns and logistics restrictions. As a result of the supply chain and distribution routes being frozen, numerous markets were impacted. However, the healthcare industry has prospered, and as a result of other effects of COVID-19, more ultrasonic blood flow measurement equipment is being used.

Global Blood Flow Measurement Devices Market: Key Developments

On June 25, 2020, Infineon Technologies AG, a German semiconductor manufacturer, announced that its Silicon Valley Innovation Center (SVIC) has entered a new agreement with Blumio, which is California-based company, to co-develop a wearable, non-invasive blood pressure sensor.

In July 2019, Arjo, which is global provider of medical devices and medical solutions, acquired substantial equity in Atlas Lift Tech, a Silicon Valley-based company offering patient handling solutions and real-time efficiency analytics.

Global Blood Flow Measurement Devices Market: Restraint

Stringent regulatory scenario is expected to hinder growth of the global flow measurement devices market. Stringent regulatory requirements and the lengthy process of FDA approvals have discouraged the OEMs of medical devices in the U.S., which are now expanding to other regions such as Asian and Latin American countries to launch newer products in the market.

Moreover, need for huge investments for R&D and clinical trials; slow approval processes; and minimal return on investment for the stakeholders is also expected to limit growth of the global flow measurement devices market.

Key Players

Major players operating in the global blood flow measurement devices market include Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc., Ace Medicals, Carolina Medical Plc, and Compumedics Ltd.

Table of Content

Table of Contents

*Browse 27 market data tables and 31 figures on “Global Blood Flow Measurement Devices Market” - Global forecast to 2030

Segmentation

Detailed Segmentation:

- Frequently Asked Questions -

What is the current market size and compound annual growth rate (CAGR) of the global blood flow measurement devices market during the forecast period (2022-2030)?

Global blood flow measurement devices market size is estimated to be valued at US$ 639.5 million in 2022 and is expected to exhibit a CAGR of 8.8 % between 2022 and 2030.

What are the major factors driving the market growth?

Factors such as increasing prevalence of peripheral vascular diseases and increasing development of biodegradable flow measurement devices are expected to drive the market growth.

Which is the leading application segment in the market?

Cardiovascular Disease is the leading application segment in the market.

What are the key factors hampering growth of the market?

The major factors hampering growth of the market include stringent regulatory scenario.

Which are the major players operating in the market?

Major players operating in the market include Arjo, Atys Medical, Compumedics Ltd., Cook Medical Inc., Deltex Medical Ltd., GF Health Products, Inc., Medistim ASA, Moor Instruments Ltd., Perimed AB, Transonic Systems, Inc., Medtronics, Biomedix Inc, AKW Medicals Inc., D E Hokanson Inc., Elcat GmBH, Flowtronics Inc., Ace Medicals, Carolina Medical Plc, and Compumedics Ltd.